Approximately one year removed from the Meningitis tragedy caused by Framingham-based compounder, New England Compounding Center, the Massachusetts House of Representatives has unanimously voted to pass a Bill that requires stricter regulation of compound pharmacies. Some of the new regulations include unannounced inspections of compounders, new reporting requirements, whistleblower protections, additional labeling requirements, continuing education classes for sterile compounders, and increased communication between State and federal regulators regarding any “adverse events” experienced by patients while taking compound medications. In addition, the Bill allows individuals to perform online checks regarding the safety record of Massachusetts compounding pharmacies. The Bill now goes to the Senate for review and approval. Stay tuned!
House Passes Stricter Regulations for Compound Pharmacies
